✦ LIBER ✦

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

✍ Scribed by López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; Quintero, G; de la Cámara, J; Candamio, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Clinical Efficacy of FOLFIRI and Bev

✍ Erin Grothey; Edward Chu 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB

PCN69 COST-EFFECTIVENESS OF FIRST-LINE C

✍ M Gyldmark; R Aultman; U Siebert; E Sabate 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Treatment Patterns and Clinical Outcomes

✍ Bendell, J. C.; Bekaii-Saab, T. S.; Cohn, A. L.; Hurwitz, H. I.; Kozloff, M.; Te 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 495 KB

Safety of bevacizumab treatment in combi

✍ Akihiro Tamiya; Kentaro Yamazaki; Narikazu Boku; Nozomu Machida; Takashi Kojima; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 317 KB

3065 POSTER Safety and efficacy of sunit

✍ F. Vazquez; A. Carrato; N. Starling; I. Chau; P. Hill; M.J. Lechuga; J. Tursi; R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

A phase I trial of vandetanib combined w

✍ Elwyn C. Cabebe, George A. Fisher, Branimir I. Sikic 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 112 KB